常染色体显性阿尔茨海默病临床前期的主观记忆抱怨
结果显示携带者自我报告的主观记忆抱怨(SMC)高于非携带者,而研究伙伴报告的SMC组间无差异,但在携带者中随年龄增长而增加、与海马体积负相关。结论认为自我报告的SMC可能是临床前AD的相对早期指标。
要点
- 认知未受损的PSEN-1 E280A携带者自我报告SMC高于非携带者。
- 研究伙伴报告的SMC在携带者中随年龄增长而增加,接近临床发病时更明显。
- 自我报告SMC或可作为临床前AD的早期指标。
核心结论
- 认知未受损的PSEN-1携带者存在升高的主观记忆抱怨,自我报告SMC可能是临床前AD的相对早期指标。
研究设计与样本
- 参与者同时接受结构MRI和认知测试。
主要发现
- 自我报告的SMC在携带者中高于非携带者(p = 0.02)。
- 研究伙伴报告的SMC在两组间无差异(p = 0.21),但在携带者中随年龄增长而增加(r = 0.66,p < 0.001)。
- 在携带者中,研究伙伴报告的SMC与海马体积呈负相关(r = -0.35,p = 0.08)。
临床怎么用
- 在临床前AD评估中,应关注患者自我报告的主观记忆抱怨,尤其对于已知ADAD突变携带者。
- 研究伙伴报告的SMC可能在更接近临床发病时出现变化,需结合年龄和海马体积等指标综合判断。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To cross-sectionally study subjective memory complaints (SMC) in autosomal dominant Alzheimer disease (ADAD). METHODS: We examined self-reported and study partner-based SMC in 52 young, cognitively unimpaired individuals from a Colombian kindred with early-onset ADAD. Twenty-six carried the PSEN-1 E280A mutation, averaging 7 years of age younger than the kindred's expected clinical onset. Twenty-six were age-matched noncarriers. Participants also underwent structural MRI and cognitive testing. RESULTS: Self-reported SMC were greater in carriers than noncarriers (p = 0.02). Study partner-based SMC did not differ between groups (p = 0.21), but in carriers increased with age (r = 0.66, p < 0.001) and decreased with hippocampal volume (r = -0.35, p = 0.08). CONCLUSIONS: Cognitively unimpaired PSEN-1 carriers have elevated SMC. Self-reported SMC may be a relatively early indicator of preclinical AD, while partner- reported SMC increases later in preclinical AD, closer to clinical onset.
引用
- Norton DJ, Amariglio R, Protas H, et al. Subjective memory complaints in preclinical autosomal dominant Alzheimer disease. Neurology. 2017. PMID: 28878053. doi:10.1212/WNL.0000000000004533
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。